Zdrowie i gospodarka · 17/10/2018
FDA Announces Pediatric Cancer Target Lists for Oncology Drug Development
The FDA has created two lists of molecular targets relevant to pediatric cancer, one for targets with evidence of relevance and another for targets with limited relevance, to inform industry on pediatric study requirements for new cancer drugs.
Source: Federal Register — Food and Drug AdministrationOpen original release →